But despite progress in developing innovative treatments and revisions to international treatment guidelines 1 for CKD in diabetes, patients have often not received the recommended standard of care 3.

Purpose The evidence evaluating the efficacy of i.v. versus oral iron for the treatment of iron deficiency in non-hemodialysis-dependent patients with chronic kidney disease (CKD) is reviewed.

Credit: Getty Images Drugs for diabetic kidney disease treatment have greatly expanded ... Overcoming Therapeutic Inertia Despite advances in drug therapy, patient outcomes have not improved ...

Otsuka Holdings Co (JP:4578) has released an update. Otsuka Holdings Co. has reported positive interim results from their Phase 3 trial of sibeprenlimab, a promising treatment for immunoglobulin A ...

The cystatin C assay market is set for significant expansion as the global healthcare landscape shifts toward early detection ...